These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18697203)

  • 1. Kinetics of repression by modified p53 on the PDGF beta-receptor promoter.
    Yang W; Wetterskog D; Matsumoto Y; Funa K
    Int J Cancer; 2008 Nov; 123(9):2020-30. PubMed ID: 18697203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor.
    Uramoto H; Wetterskog D; Hackzell A; Matsumoto Y; Funa K
    J Cell Sci; 2004 Oct; 117(Pt 22):5323-31. PubMed ID: 15454570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of platelet-derived growth factor beta-receptor expression by DeltaNp73 in neuroblastoma.
    Wetterskog D; Moshiri A; Ozaki T; Uramoto H; Nakagawara A; Funa K
    Mol Cancer Res; 2009 Dec; 7(12):2031-9. PubMed ID: 19952113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
    J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
    Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
    J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
    Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
    Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter-binding and repression of PDGFRB by c-Myc are separable activities.
    Mao DY; Barsyte-Lovejoy D; Ho CS; Watson JD; Stojanova A; Penn LZ
    Nucleic Acids Res; 2004; 32(11):3462-8. PubMed ID: 15226411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C terminus of p53 family proteins is a cell fate determinant.
    Harms KL; Chen X
    Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc.
    Sankar N; Baluchamy S; Kadeppagari RK; Singhal G; Weitzman S; Thimmapaya B
    Oncogene; 2008 Sep; 27(43):5717-28. PubMed ID: 18542060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and p73 in suppression of Myc-driven lymphomagenesis.
    Griesmann H; Schlereth K; Krause M; Samans B; Stiewe T
    Int J Cancer; 2009 Jan; 124(2):502-6. PubMed ID: 18942718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of mitotic checkpoint gene MAD1 by p53.
    Chun AC; Jin DY
    J Biol Chem; 2003 Sep; 278(39):37439-50. PubMed ID: 12876282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73.
    Rother K; Dengl M; Lorenz J; Tschöp K; Kirschner R; Mössner J; Engeland K
    FEBS Lett; 2007 Mar; 581(6):1166-72. PubMed ID: 17336302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.
    Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H
    DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
    Ho JS; Ma W; Mao DY; Benchimol S
    Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.
    Nguyen TT; Cho K; Stratton SA; Barton MC
    Mol Cell Biol; 2005 Mar; 25(6):2147-57. PubMed ID: 15743813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73.
    Krause K; Haugwitz U; Wasner M; Wiedmann M; Mössner J; Engeland K
    Biochem Biophys Res Commun; 2001 Jun; 284(3):743-50. PubMed ID: 11396965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
    Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
    Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.